Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Fallopian Tube Cancer
Related studies linked through entity extraction aliases.
A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
- Status
- RECRUITING
- Phase
- NA
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT)
- Status
- TERMINATED
- Phase
- PHASE3
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
- Status
- RECRUITING
- Phase
- NA
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Investigate LYL797 in Adults With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
KORE-INNOVATION: a Prospective, Multi-site Clinical Trial to Implement and Analyse the Effects of an Innovative Perioperative Care Pathway to Reduce Complications for Patients with Ovarian Cancer
- Status
- COMPLETED
- Phase
- NA
Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
- Status
- RECRUITING
- Phase
- NA
Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tempus Priority Study: A Pan-tumor Observational Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A